Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older Adults
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary Care
    Release Date:
    Partner: Conquer Cancer, the ASCO Foundation
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo
    Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management
    Release Date:
    Partner: Beijing Guangda Precision Medicine Research Center
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology China
    Post-COVID Conditions: Potential Diagnosis, Testing, Management, and Ongoing Research
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimizing Antimicrobial Stewardship Program in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Saudi Arabia
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Pharmacokinetics-pharmacodynamics (PK-PD) of aztreonam-avibactam (ATM-AVI) in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Austria, Denmark, Finland, Germany, Italy, Netherlands, Norway, Romania, Spain, Sweden, United Kingdom
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Treatment Optimization in ALK-positive Metastatic Non-Small Cell Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Netherlands, Norway, Portugal, Spain, Swaziland, Sweden, USA, United Kingdom
    Immunotherapy in High-risk Non-Muscle Invasive Bladder Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Advances in Migraine Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    2022/2023 Global Obesity ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Evolving Concepts in Biosimilar Optimization in Inflammatory Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Underlying medical conditions and other risk factors, higher risk of severe COVID-19 (European)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Building Capacity to Address Health Disparities in the US through AMS Telehealth and Tele-mentoring
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital USA
    2022/2023 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    2023 Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Antimicrobial Resistance Testing and Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    Medication Error Reduction Strategies in the Hospital Setting
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    2022/2023 Global Cachexia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All